Cargando…
Drug-Virus Interaction: Effect of Administration of Recombinant Adenoviruses on the Pharmacokinetics of Docetaxel in a Rat Model
Modern cancer therapy combines recombinant viruses with traditional chemotherapeutic agents that are metabolized by hepatic cytochrome P450 3A4 (CYP3A4). A single dose of recombinant adenovirus (Ad) expressing beta-galactosidase (AdlacZ) significantly alters CYP3A2, the correlate of CYP3A4, in rats...
Autores principales: | Wonganan, Piyanuch, Zamboni, William C., Strychor, Sandra A., Dekker, Joseph D., Croyle, Maria A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765861/ https://www.ncbi.nlm.nih.gov/pubmed/19110543 http://dx.doi.org/10.1038/cgt.2008.99 |
Ejemplares similares
-
PEGylated Adenoviruses: From Mice to Monkeys
por: Wonganan, Piyanuch, et al.
Publicado: (2010) -
Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection
por: Callahan, Shellie M, et al.
Publicado: (2008) -
Butoxy Mansonone G Inhibits STAT3 and Akt Signaling Pathways in Non-Small Cell Lung Cancers: Combined Experimental and Theoretical Investigations
por: Mahalapbutr, Panupong, et al.
Publicado: (2019) -
The prominent impairment of liver/intestinal cytochrome P450 and intestinal drug transporters in sepsis-induced acute kidney injury over acute and chronic renal ischemia, a mouse model comparison
por: Sukkummee, Warumphon, et al.
Publicado: (2019) -
Effect of the Phragmitis rhizoma Aqueous Extract on the Pharmacokinetics of Docetaxel in Rats
por: Shin, Sarah, et al.
Publicado: (2019)